Nørgaard JN, Abildgaard N, Lysén A, Tsykunova G, Vangsted AJ, João C, Remen N, Osnes L, Stokke C, Connelly JP, Revheim MR, Schjesvold F(2025) Progression-Free and Overall Survival After KRd Consolidation in FDG PET/CT Positive Patients After ASCT: A Phase II Study (CONPET) Clin Lymphoma Myeloma Leuk(in press) DOI 10.1016/j.clml.2025.10.020, PubMed 41314938
van de Donk NWCJ, Moreau P, San-Miguel JF, Mateos MV, Dimopoulos MA, Zweegman S, Gay F, Engelhardt M, Mina R, Zamagni E, Delforge M, Beksac M, Spencer A, Schjesvold F, Driessen C, Kaiser M, Perrot A, Wäsch R, Korst CLBM, Broijl A, Touzeau C, Manier S, Hajek R, Bila J, Seval GCet al.(2025) Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network Hemasphere, 9(11), e70260 DOI 10.1002/hem3.70260, PubMed 41306326
Bolli N, D'Agostino M, Bagratuni T, Boccadoro M, Cavo M, Driessen C, Einsele H, Engelhardt M, Gay F, Gutiérrez NC, Hájek R, Holien T, João C, Kaiser M, Kortüm KM, Leypoldt L, Moreau P, Musto P, Ocio EM, Raab MS, Rasche L, Schjesvold F, Sevcikova T, Terpos E, Touzeau Cet al.(2025) European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma Hemasphere, 9(10), e70216 DOI 10.1002/hem3.70216, PubMed 41089883
